RTOG #89-06: A phase I study to evaluate intraoperative radiation therapy and the hypoxic cell sensitizer etanidazole in locally advanced malignancies

This publication has 12 references indexed in Scilit:

• Final report of the phase I trial of continuous infusion etanidazole (SR 2508): A radiation therapy oncology group study
  International Journal of Radiation Oncology*Biology*Physics, 1992
• Distribution of etanidzole into human brain tumors: Implications for treating high grade gliomas
  International Journal of Radiation Oncology*Biology*Physics, 1992
• Effective Surgical Adjuvant Therapy for High-Risk Rectal Carcinoma
  New England Journal of Medicine, 1991
• A prospective study of treatment techniques to minimize the volume of pelvic small bowel with reduction of acute and late effects associated with pelvic irradiation
  International Journal of Radiation Oncology*Biology*Physics, 1986
• Clinical trials of radiosensitizers: What should we expect?
  International Journal of Radiation Oncology*Biology*Physics, 1984
• Clinical trials of hypoxic cell sensitizers
  International Journal of Radiation Oncology*Biology*Physics, 1982
• SR-2508: A 2-nitroimidazole amide which should be superior to misonidazole as a radiosensitizer for clinical use
  International Journal of Radiation Oncology*Biology*Physics, 1981
• The optimum time for irradiation relative to tumour concentration of hypoxic cell sensitizers
  The British Journal of Radiology, 1980
• Hypoxic Sensitizers — Implications for Radiation Therapy
  New England Journal of Medicine, 1979
• Sample size and power determination for stratified clinical trials
  Journal of Statistical Computation and Simulation, 1978